FDA permits marketing of the first game-based digital therapeutic device to improve attention function in children with ADHD. The game-based device, EndeavorRx, is for pediatric patients ages 8 to12 years old with primarily inattentive or combined-type ADHD
Read more: FDA Permits Marketing of First Game-Based Digital Therapeutic to Improve Attention Function in Children with ADHD